Expert Opinion on Biological Therapy (ISSN 1471-2598 [print], 1744-7682 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on all aspects of biological therapy, providing expert opinion on the scope for future development.
The Editors welcome:
Reviews covering gene therapy and gene transfer technologies; therapeutic peptides and proteins; vaccines and antibodies; cell-based therapies, stem cell therapies and regenerative medicine; tissue-based therapies
Drug Evaluations reviewing the clinical data on a particular biological agent
Original research papers reporting the results of clinical investigations on biological agents and biotherapeutic-based studies with a strong link to clinical practice
The audience consists of scientists and managers in the healthcare and biopharmaceutical industries and others closely involved in the development and application of biological therapies for the treatment of human disease. 

EDITOR IN CHIEF
Michael Morse: Duke University Medical Centre, USA
EDITORIAL BOARD
Ivo Abraham: The University of Arizona, USA 
Mauro Alaibac: University of Padua, Italy 
Anthony Atala: Wake Forest Institute for Regenerative Medicine, USA 
Constantin Baxevanis: Saint Savas Cancer Hospital, Greece 
Alessandro Busca: San Giovanni Battista Hospital, Italy 
Laurent Peyrin-Biroulet: University Hospital of Nancy, France 
Cesar Borlongon: University of South Florida, USA 
George Calin: Anderson Cancer Center, USA 
Michele Caraglia: Seconda Universita degli Studi di Napoli, Italy 
Maria Castro: The University of Michigan School of Medicine, USA 
William Cho: Queen Elizabeth Hospital, Hong Kong 
Myron S Czuczman: Roswell Park Cancer Institute, USA 
Angus Dalgleish: St George's Hospital Medical School, UK 
Silvo Danese: Humanitas Research Hospital, Italy 
Constantin A Dasanu: University of California, USA 
Dwaine Emerich: InCytu Inc., USA 
Steven Feldman: Wake Forest School of Medicine, USA 
Arthur E Frankel: Scott & White Cancer Research Institute, USA 
Allan Goldstein: The George Washington University School of Medicine, USA 
Peter J Hudson: Avipep Pty Ltd., Australia 
David Kirn: Imperial College School of Medicine, UK 
Herwig Kollaritsch: Medical University of Vienna, Italy 
Robert Kreitman: National Cancer Institute, USA 
E Michael Lewiecki: University of New Mexico, USA 
M Alan Menter: Baylor University Medical Center, USA 
Alireza Minagar: Louisiana State University Health Sciences Center, USA 
Chi-Chiu Mok: University of Hong Kong, Hong Kong 
Gorka Orive: University of the Basque Country, Spain 
Ian Pringle: Trinity College, Oxford University, UK 
Nikolai Rainov: Martin Luther University Halle-Wittenberg, Germany 
Dario Sangiolo: IRCC - Institute for Cancer Research and Treatment, Italy 
Daniele Santini: University Campus Bio-Medico, Italy 
Susan Slovin: Memorial Sloan Kettering Cancer Center, USA 
Michael Vajdy: EpitoGenesis, Inc., USA 
Giovanni Vital e: University of Milan, Italy 
Heinz Wiendl: Universtiy of Munster, Germany